Samsung Seoul Hospital Selected for Advanced Gene Therapy Development Platform Project
15 Participating Companies and 13 Partner Companies Participate
Large-Scale Project for Developing Treatments for Rare and Intractable Diseases
[Asia Economy Reporter Lee Gwan-joo] Samsung Seoul Hospital announced on the 23rd that it has recently signed an agreement after being selected for the new unit of the research-oriented hospital fostering R&D project led by the Ministry of Health and Welfare, with the project titled "Establishment of an Advanced Gene Therapy Development Platform for Rare and Intractable Diseases."
Samsung Seoul Hospital demonstrated its research capabilities by being selected for three consecutive years, following precision medicine in 2020 and digital therapeutics devices in 2021.
Samsung Seoul Hospital expanded its regenerative medicine platform, the Stem Cell Regenerative Medicine Research Institute, into the Cell and Gene Therapy Research Institute in December last year, and applied for this project aiming to develop advanced gene therapies for rare and intractable diseases.
In particular, this gene therapy unit is a large-scale national project promoted through a consortium formed with Seoul National University Bundang Hospital and Sungkyunkwan University, along with 15 participating companies including Samsung Bioepis and 13 cooperating companies. The research budget includes 18.6 billion KRW in government funding and 20.2 billion KRW in contributions from the hospital and participating companies, totaling 38.8 billion KRW.
Hot Picks Today
As Samsung Falters, Chinese DRAM Surges: CXMT Returns to Profit in Just One Year
- "Most Americans Didn't Want This"... Americans Lose 60 Trillion Won to Soaring Fuel Costs
- Man in His 30s Dies After Assaulting Father and Falling from Yongin Apartment
- Samsung Union Member Sparks Controversy With Telegram Post: "Let's Push KOSPI Down to 5,000"
- "Why Make Things Like This?" Foreign Media Highlights Bizarre Phenomenon Spreading in Korea
The principal investigator of this new unit, Ji-hoon Lee, Director of the Gene Therapy Research Center (Professor of Pediatrics), said, "Gene therapy has been researched for the past 20 years, but only recently have successful therapies entered the market, requiring cutting-edge and highly complex technology," adding, "We will do our best to make the open platform for gene therapy development a new seed of hope for domestic patients suffering from rare and intractable diseases who have no available treatments."
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
